Literature DB >> 83651

Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon.

I Heron, M Hokland, K Berg.   

Abstract

Mononuclear cells from the blood of healthy normal humans were kept in cultures under nonstimulating conditions for 16 hr in the presence or absence of human interferon. The relative quantities of HLA antigens and beta(2)-microglobulin on the cultured cells were determined by quantitative immunofluorescence (fluorescence-activated cell sorter) and by the capacity of cells to absorb out cytotoxic antibodies against the relevant antigens. Interferons of different origin and purities enhanced the expression of HLA antigens and beta(2)-microglobulins, whereas membrane immunoglobulins and antigens recognized by antiserum raised against human brain and T cells were the same on interferon-treated and control cells. Similar interferon effects were observed on an Epstein-Barrvirus-negative Burkitt lymphoma cell line. The enhanced expression of histocompatibility antigen subsequent to intereferon treatment was observed on B- and T-enriched lymphocyte populations and was found to be dose dependent with the optimum with "physiological" concentrations of interferon. Pretreatment of lymphocytes with interferon for 2 hr was found to be as effective as having interferon present during the total culture period. The interferon-induced enhancement of antigen expression on cells was dependent on active protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 83651      PMCID: PMC393150          DOI: 10.1073/pnas.75.12.6215

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  DIFFERENCES IN INTERFERON CONTENT IN TISSUES OF MICE OF VARIOUS AGES INFECTED WITH COXSACKIE B1 VIRUS.

Authors:  H HEINEBERG; E GOLD; F C ROBBINS
Journal:  Proc Soc Exp Biol Med       Date:  1964-04

2.  RELATIONSHIP OF INTERFERON PRODUCTION TO VIRUS GROWTH IN VIVO.

Authors:  S BARON; H G DUBUY; C E BUCKLER; M L JOHNSON
Journal:  Proc Soc Exp Biol Med       Date:  1964-11

3.  Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles.

Authors:  M Hokland; P Hokland; I Heron
Journal:  Int Arch Allergy Appl Immunol       Date:  1978

4.  The actions of interferon are potentiated at elevated temperature.

Authors:  I Heron; K Berg
Journal:  Nature       Date:  1978-08-03       Impact factor: 49.962

5.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

6.  Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogeneic cells.

Authors:  P Lindahl-Magnusson; P Leary; I Gresser
Journal:  Nat New Biol       Date:  1972-05-24

7.  Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes.

Authors:  P Lindahl; P Leary; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

8.  Growth inhibition of human lymphoblastoid Daudi cells in vitro by interferon preparations.

Authors:  J Hilfenhaus; H Damm; H E Karges; K F Manthey
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

9.  Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells.

Authors:  P Lindahl; I Gresser; P Leary; M Tovey
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

10.  Regulatory effect of interferon on T cells in vitro.

Authors:  I Heron; K Berg; K Cantell
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

View more
  48 in total

1.  Induction of auto-logous human cytotoxic T lymphocytes (CTL) from peripheral blood against tumor cells.

Authors:  T Ohno
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

2.  The effect of recombinant interferon-alpha on lymphocyte subpopulations and HLA-DR expression on liver tissue of HBV-positive individuals.

Authors:  Y K Yoo; J B Gavaler; K Chen; T L Whiteside; D H van Thiel
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

Review 3.  Biological response modifiers in the management of patients with breast cancer.

Authors:  D L Longo; L C Hartmann
Journal:  Breast Cancer Res Treat       Date:  1990-09       Impact factor: 4.872

4.  Immunohistochemical study of HLA class 1 antigens on the hepatocytes of patients with chronic hepatitis B.

Authors:  K Manabe; G Yamada; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1986-08

Review 5.  IFN-induced modulation of histocompatibility antigens on human cells. Background, mechanisms and perspectives.

Authors:  M Hokland; P Basse; J Justesen; P Hokland
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

6.  Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease.

Authors:  K Koretz; F Momburg; H F Otto; P Möller
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

7.  Pleiotropic activities of human interferons are mediated by multiple response pathways.

Authors:  R L Forti; W M Mitchell; W C Hubbard; R J Workman; J T Forbes
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

8.  Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta.

Authors:  A Dolei; M R Capobianchi; F Ameglio
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

9.  In vivo induction of HLA molecules in patients with myeloproliferative syndrome during IFN alpha treatment.

Authors:  C A Müller; J Walz; R Zinser; H J Bühring; B Steinke; H Schmidt
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

10.  Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci.

Authors:  F Ameglio; M R Capobianchi; A Dolei; R Tosi
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.